共 50 条
[43]
Anti-DNA topoisomerase I antibody IgG titer correlates with disease activity in systemic sclerosis.
[J].
ARTHRITIS AND RHEUMATISM,
2001, 44 (09)
:S326-S326
[47]
Assessment of disease outcome measures in systemic sclerosis
[J].
Nature Reviews Rheumatology,
2022, 18
:527-541
[49]
PUVA therapy of skin sclerosis in systemic sclerosis and limited sclerosis.
[J].
ARTHRITIS AND RHEUMATISM,
1999, 42 (09)
:S190-S190
[50]
Ability of commonly used outcome measures to distinguish subsets of skin involvement in systemic sclerosis.
[J].
ARTHRITIS AND RHEUMATISM,
2006, 54 (09)
:S482-S482